These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 34592028)
1. Preventing a New Tuskegee: Food and Drug Administration Oversight of Overseas Research Must Match That in the United States. White CM; White LR J Clin Pharmacol; 2022 Mar; 62(3):434-437. PubMed ID: 34592028 [No Abstract] [Full Text] [Related]
2. Protecting clinical research and human participants: considerations for domestic and foreign clinical trials. Beach JE J Biolaw Bus; 2002; 5(3):41-5. PubMed ID: 12816117 [TBL] [Abstract][Full Text] [Related]
3. Who watches the watchmen? Nature; 2011 Aug; 476(7359):125. PubMed ID: 21833048 [No Abstract] [Full Text] [Related]
4. Introduction to special issue of Accountability in Research on the review and approval of biomedical research proposals: a call for a centralized national human research protections system. Mann H; Shamoo AE Account Res; 2006; 13(1):1-9. PubMed ID: 16770856 [No Abstract] [Full Text] [Related]
5. Ethical oversight of research in developing countries. Kass N; Dawson L; Loyo-Berrios NI IRB; 2003; 25(2):1-10. PubMed ID: 12833901 [No Abstract] [Full Text] [Related]
6. Vulnerability, scientific research and AIDS. Diniz D Dev World Bioeth; 2001 Nov; 1(2):153-5. PubMed ID: 12872758 [No Abstract] [Full Text] [Related]
7. Protecting human research subjects. Fiscus PW J Biolaw Bus; 2001; 4(4):18-22. PubMed ID: 12751493 [TBL] [Abstract][Full Text] [Related]
8. Another meeting on the Helsinki Declaration. Bull Med Ethics; 2001 Mar; (166):13-4. PubMed ID: 11878333 [No Abstract] [Full Text] [Related]
9. Commentary on UNAIDS 18 guidance points. van Bogaert DK Dev World Bioeth; 2001 Nov; 1(2):142-7. PubMed ID: 12872755 [No Abstract] [Full Text] [Related]
10. Cancer research and therapy: a view from Norway. Ruyter KW Perspectives Prof; 2000; 20(1):E5. PubMed ID: 15115042 [No Abstract] [Full Text] [Related]
11. Challenges in human subject protection. Nightingale SL Food Drug Law J; 1995; 50(4):493-501. PubMed ID: 10343016 [No Abstract] [Full Text] [Related]
12. Raising suspicions with the Food and Drug Administration: detecting misconduct. Hamrell MR Sci Eng Ethics; 2010 Dec; 16(4):697-704. PubMed ID: 20842536 [TBL] [Abstract][Full Text] [Related]
13. As use of foreign drug trials grows, FDA oversight may not be keeping up. Mitka M JAMA; 2010 Aug; 304(8):843-4. PubMed ID: 20736460 [No Abstract] [Full Text] [Related]
14. International Clinical Research and Justice in the Millum J Perspect Biol Med; 2020; 63(2):374-388. PubMed ID: 33416659 [TBL] [Abstract][Full Text] [Related]
15. Changing the paradigm: new directions in federal oversight of human research. Koski G J Pediatr Gastroenterol Nutr; 2003; 37 Suppl 1():S2-6. PubMed ID: 14685070 [TBL] [Abstract][Full Text] [Related]
18. The effect of the current regulatory environment on clinical research: An overview. Finlayson SR Surgery; 2009 Jun; 145(6):626-30. PubMed ID: 19486763 [No Abstract] [Full Text] [Related]
19. The impact of escalating regulatory requirements on the conduct of clinical research. Gordon BG; Kessinger A; Mann SL; Prentice ED Cytotherapy; 2003; 5(4):309-13. PubMed ID: 12944237 [TBL] [Abstract][Full Text] [Related]
20. Adolescents and Drug Development: Commentary on a Dawning Paradigm Shift. Kearns GL; van den Anker JN J Clin Pharmacol; 2021 Jun; 61(6):740-743. PubMed ID: 33797778 [No Abstract] [Full Text] [Related] [Next] [New Search]